Literature DB >> 16861141

Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.

Aleksandra Szczepankiewicz1, Janusz K Rybakowski, Aleksandra Suwalska, Maria Skibinska, Anna Leszczynska-Rodziewicz, Monika Dmitrzak-Weglarz, Piotr M Czerski, Joanna Hauser.   

Abstract

A relationship between response to lithium prophylaxis and T-50C polymorphism of glycogen synthase kinase-3beta (GSK-3beta) gene was investigated in 89 bipolar patients (41 male and 48 female) who have been taking lithium for at least 5 years. The patients were delineated as excellent responders, partial responders and non-responders to lithium. The results obtained suggest that this polymorphism may not be related to the degree of prophylactic lithium response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861141     DOI: 10.1080/15622970600554711

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  24 in total

Review 1.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

Review 2.  The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.

Authors:  Claudia Pisanu; Urs Heilbronner; Alessio Squassina
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 3.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

Review 4.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

5.  Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.

Authors:  Guodi Chen; Jun Tang; Guangwei Yu; Yiping Chen; Liancong Wang; Yao Zhang
Journal:  Mol Biol Rep       Date:  2014-06-15       Impact factor: 2.316

Review 6.  Lithium's role in neural plasticity and its implications for mood disorders.

Authors:  J D Gray; B S McEwen
Journal:  Acta Psychiatr Scand       Date:  2013-04-26       Impact factor: 6.392

7.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 8.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

9.  Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.

Authors:  Jiajun Shi; Jacqueline K Wittke-Thompson; Judith A Badner; Eiji Hattori; James B Potash; Virginia L Willour; Francis J McMahon; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

10.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.